* If you want to update the article please login/register
In the presence of staurosporine, A549 non-small-cell lung carcinoma cells are likely to die down or non-popular cells in a concentration-dependent manner. In a resting state, a continuous SSP treatment of A549 cells will keep PGCCs for at least two months. Following the removal of SSP, A549 PGCCs begin to divide and display a proliferation pattern and cellular morphology that is indistinguishable from cells where PGCCs first appeared.
Source link: https://doi.org/10.1155/2018/1754085
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions